Clinical Trials Management Today's Research... Tomorrow's Cures


Atopic Dermatitis (Eczema)

This study is for participants, ages 6+, with Atopic Dermatitis (AD), also called Eczema.  Symptoms must be present for at least three months if between the ages 6-17, or 6 months if 18+.

The study investigates a topical cream, applied once daily, to reduce inflammation and improve symptoms associated with AD. 2 in 3 participants (67%) will receive the actual drug, and 1 in 3 participants (33%) will receive a placebo.

Study participants will receive compensation for their participation.


This study is open at our Northshore and Southshore locations,

Call us at:  

504-455-1310 (Metairie) or

985-900-2400 (Covington) to see if you qualify.


You may also fill out the contact form below:

Send us questions or comments

The submission was incomplete!

    • captcha
      (Please enter the caption to the right)